Early and sustained improvements in patient-reported outcomes with tralokinumab in combination with topical corticosteroids as needed in moderate-to-severe atopic dermatitis

被引：0
|
作者：
Elewski, B. E. [1 ]
Staender, S. [2 ,3 ]
Zirwas, M. [4 ]
Silvestre, J. F. [5 ]
Kalia, S. [6 ,7 ,8 ]
Gutermuth, J. [9 ,10 ]
Mark, T. [11 ]
Tindberg, A. M. [11 ]
Silverberg, J. I. [12 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Univ Hosp Munster, Dept Dermatol, Munster, Germany
[3] Univ Hosp Munster, Interdisciplinary Competence Ctr Chron Pruritus K, Munster, Germany
[4] Prob Med Res, Columbus, OH USA
[5] Hosp Gen Univ Alicante, Dermatol Dept, Alicante, Spain
[6] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC, Canada
[7] Vancouver Coastal Hlth, Vancouver, BC, Canada
[8] BC Childrens Hosp Res Inst, Vancouver, BC, Canada
[9] Univ Ziekenhuis Brussel, Dept Dermatol, Brussels, Belgium
[10] Vrije Univ Brussel, Brussels, Belgium
[11] LEO Pharma AS, Ballerup, Denmark
[12] George Washington Univ, Sch Med & Hlth Sci, Depat Dermatol, Washington, DC 20052 USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 184卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
385
引用
收藏
页码：E83 / E84
页数：2
相关论文
共 50 条
  • [31] LONG-TERM EFFICACY OF TRALOKINUMAB IN ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Wollenberg, Andreas
    Paller, Amy S.
    Bewley, Anthony
    Cork, Michael
    Hong, Chih-Ho
    Soong, Weily
    Oland, Christian Bjerregard
    Taveira, Christian Moreira
    Gjerum, Le
    Blauvelt, Andrew
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 54 - 54
  • [32] Tralokinumab therapy for moderate-to-severe atopic dermatitis: Clinical outcomes with targeted IL-13 inhibition
    Simpson, Eric L.
    Guttman-Yassky, Emma
    Eichenfield, Lawrence F.
    Boguniewicz, Mark
    Bieber, Thomas
    Schneider, Shannon
    Guana, Adriana
    Silverberg, Jonathan I.
    ALLERGY, 2023, 78 (11) : 2875 - 2891
  • [33] Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis
    Lio, Peter A.
    Armstrong, April
    Gutermuth, Jan
    Nosbaum, Audrey
    Sofen, Howard
    Gil, Esther Garcia
    Casillas, Marta
    Chen, Sherry
    Sun, Luna
    Pierce, Evangeline
    Elmaraghy, Hany
    Dawson, Zach
    Torres, Tiago
    DERMATOLOGY AND THERAPY, 2024, 14 (07) : 1929 - 1943
  • [34] Disagreement between physician- and patient-reported disease severity in adults with a history of moderate-to-severe atopic dermatitis
    Wei, W.
    Anderson, P.
    Gadkari, A.
    Blackburn, S.
    Moon, R.
    Piercy, J.
    Shinde, S.
    Gomez, J.
    Ghorayeb, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S23 - S23
  • [35] Topical sodium cromoglycate in the treatment of moderate-to-severe atopic dermatitis
    Moore, C
    Ehlayel, MS
    Junprasert, J
    Sorensen, RU
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1998, 81 (05) : 452 - 458
  • [36] Impact of oral abrocitinib on signs, symptoms and quality of life among adolescents with moderate-to-severe atopic dermatitis: an analysis of patient-reported outcomes
    Cork, M. J.
    McMichael, A.
    Teng, J.
    Valdez, H.
    Rojo, R.
    Chan, G.
    Zhang, F.
    Myers, D. E.
    DiBonaventura, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (03) : 422 - 433
  • [37] LEBRIKIZUMAB IMPROVES CLINICAL MANIFESTATIONS AND PATIENT-REPORTED OUTCOMES IN MODERATE-TO-SEVERE ATOPIC DERMATITIS: PHASE 2B STUDY RESULTS
    Ali, Z.
    Guttman-Yassky, E.
    Blauvelt, A.
    Eichenfield, L.
    Paller, A.
    Armstrong, A.
    Drew, J.
    Gopalan, R.
    Simpson, E.
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 32 - 32
  • [38] Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial (ADhere)
    Simpson, Eric L. L.
    Gooderham, Melinda
    Wollenberg, Andreas
    Weidinger, Stephan
    Armstrong, April
    Soung, Jennifer
    Ferrucci, Silvia
    Lima, Renata Gontijo
    Witte, Michael M. M.
    Xu, Wen
    ElMaraghy, Hany
    Natalie, Chitra R. R.
    Pierce, Evangeline
    Blauvelt, Andrew
    ADhere Investigators
    JAMA DERMATOLOGY, 2023, 159 (02) : 182 - 191
  • [39] Definition of treatment goals in terms of clinician-reported disease severity and patient-reported outcomes in moderate-to-severe adult atopic dermatitis: a systematic review
    Iannone, Michela
    Tonini, Giulia
    Janowska, Agata
    Dini, Valentina
    Romanelli, Marco
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (08) : 1295 - 1301
  • [40] Patient Preferences in the Treatment of Moderate-to-severe Atopic Dermatitis
    Ameen, Mahreen
    Alhusaye, Raed
    Brandi, Henrik
    Bogelund, Mette
    Jensen, Henrik H.
    Reitzel, Signe B.
    Thyssen, Jacob P.
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
12345